Estimation of Out-of-Pocket Costs for Guideline-Directed Medical Therapy for Heart Failure Under Medicare Part D and the Inflation Reduction Act.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2022.5033
Abstract: This cross-sectional study estimates out-of-pocket costs of heart failure with reduced ejection fraction medication regimens in Medicare Part D under current law and the Inflation Reduction Act. read more here.
Keywords: medicare part; heart failure; inflation reduction; reduction act ... See more keywords
Medicare Part D Payments for Topical Steroids: Rising Costs and Potential Savings
Sign Up to like & getrecommendations! Published in 2017 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2017.1130
Abstract: Importance Rising pharmaceutical costs in the United States are an increasing source of financial burden for payers and patients. Although topical steroids are among the most commonly prescribed medications in dermatology, there are limited data… read more here.
Keywords: dermatology; potential savings; medicare part; topical steroids ... See more keywords
Use and Cost of Actinic Keratosis Destruction in the Medicare Part B Fee-for-Service Population, 2007 to 2015
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2018.3086
Abstract: Importance Actinic keratosis is prevalent and has the potential to progress to keratinocyte carcinoma. Changes in the use and costs of actinic keratosis treatment are not well understood in the aging population. Objective To evaluate… read more here.
Keywords: keratosis; fee service; actinic keratosis; medicare part ... See more keywords
Trends in Medicare Part B Spending on Discarded Drugs, 2017-2020.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2022.5890
Abstract: This cross-sectional study quantifies trends in discarded drug spending since the onset of mandated reporting. read more here.
Keywords: medicare part; spending discarded; trends medicare; part spending ... See more keywords
Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures
Sign Up to like & getrecommendations! Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.13969
Abstract: This cross-sectional study examines the availability and quality of published cost-effectiveness studies for drugs with the greatest Medicare Part D spending in 2016. read more here.
Keywords: availability; medicare part; studies drugs; cost effectiveness ... See more keywords
Association of Beneficiary-Level Risk Factors and Hospital-Level Characteristics With Medicare Part B Drug Spending Differences Between 340B and Non-340B Hospitals
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.0045
Abstract: Key Points Question Is per-beneficiary Medicare Part B drug spending significantly different at hospitals that are part of the federal 340B Drug Pricing Program, which can purchase outpatient drugs from manufacturers at discounted prices, compared… read more here.
Keywords: medicare part; part drug; level; drug spending ... See more keywords
Utilization of Filgrastim and Infliximab Biosimilar Products in Medicare Part D, 2015-2019
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.1117
Abstract: This cross-sectional study examines utilization trends for filgrastim and infliximab products and their biosimilars to understand whether biosimilars are associated with reduced spending in Medicare Part D. read more here.
Keywords: medicare part; biosimilar products; utilization filgrastim; infliximab biosimilar ... See more keywords
Analysis of Anti-Vascular Endothelial Growth Factor Injection Claims Data in US Medicare Part B Beneficiaries From 2012 to 2015.
Sign Up to like & getrecommendations! Published in 2019 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2019.1971
Abstract: Importance The frequency of anti-vascular endothelial growth factor (VEGF) injections has grown exponentially with the introduction of bevacizumab, ranibizumab, and most recently aflibercept. The cost associated with these medications has garnered significant national attention, warranting… read more here.
Keywords: part beneficiaries; bevacizumab; part; 2012 2015 ... See more keywords
How protected classes in Medicare Part D influence U.S. drug sales, utilization, and price.
Sign Up to like & getrecommendations! Published in 2020 at "Health economics"
DOI: 10.1002/hec.4006
Abstract: When the Medicare Part D prescription drug benefit was implemented in 2006, six drug classes were designated "protected classes." Because responsibility for obtaining favorable drug prices depends on private insurers' abilities to negotiate with pharmaceutical… read more here.
Keywords: sales utilization; protected classes; medicare part; drug ... See more keywords
How access to addictive drugs affects the supply of substance abuse treatment: Evidence from Medicare Part D.
Sign Up to like & getrecommendations! Published in 2022 at "Health economics"
DOI: 10.1002/hec.4530
Abstract: This paper documents how substance abuse treatment (SAT) providers and services respond to increases in population-level opioid addiction. I do this by exploiting the implementation of Medicare Part D as an exogenous increase in the… read more here.
Keywords: medicare part; abuse treatment; treatment; substance abuse ... See more keywords
The impact of health insurance expansion on physician treatment choice: Medicare Part D and physician prescribing
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Health Economics and Management"
DOI: 10.1007/s10754-017-9211-2
Abstract: We test the effect of the introduction of Medicare Part D on physician prescribing behavior by using data on physician visits from the National Ambulatory Medical Care Survey (NAMCS) 2002–2004 and 2006–2009 for patients aged… read more here.
Keywords: part; part physician; medicare part; physician prescribing ... See more keywords